Cognition Therapeutics, Inc. (CGTX) Tops Q2 EPS by 4c

Cognition Therapeutics, Inc. (NASDAQ: CGTX) reported Q2 EPS of ($0.25), $0.04 better than the analyst estimate of ($0.29).

For earnings history and earnings-related data on Cognition Therapeutics, Inc. (CGTX) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Deutsche Bank monitors UK auto sales as Chinese exports grow
• Bernstein SocGen on Meta Platforms Inc. (META): 'Risk-reward remains attractive'